Fund HoldingsCatalio Capital Management, LP

Total Portfolio Value
$532.10M
Total Bought
$251.65M
Total Sold
$213.15M
Net Transaction
+$38.50M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
AVALYN PHARMACEUTICALS INC01,675,830+1,675,830055,16810.37%+55,168
JOHNSON & JOHNSON(JNJ)0138,946+138,946035,2886.63%+35,288
PARABILIS MEDICINES INC0824,043+824,043022,5544.24%+22,554
PROTAGONIST THERAPEUTICS INC0106,799+106,799013,0912.46%+13,091
GILEAD SCIENCES INC(GILD)163,905269,309+105,40422,84334,0246.39%+11,181
SEPTERNA INC(SEPN)294,360536,152+241,7927,07317,9563.37%+10,882
AXSOME THERAPEUTICS INC.(AXSM)043,182+43,182010,5701.99%+10,570
KAILERA THERAPEUTICS INC0468,750+468,750010,3271.94%+10,327
ODYSSEY THERAPEUTICS INC0457,839+457,83908,5661.61%+8,566
ASCENDIS PHARMA A/S(ASND)031,759+31,75908,4711.59%+8,471
NATERA INC(NTRA)70,90782,181+11,27414,18122,3084.19%+8,127
KARDIGAN INC0312,500+312,50007,4531.40%+7,453
HEARTFLOW INC(HTFL)403,588583,055+179,4679,81917,1073.21%+7,288
DEFINIUM THERAPEUTICS INC(DFTX)1,037,984562,672-475,31219,61826,4684.97%+6,850
4D MOLECULAR THERAPEUTICS IN0471,254+471,25406,2681.18%+6,268
MINERALYS THERAPEUTICS INC(MLYS)439,041648,722+209,68111,89417,5033.29%+5,609
INCYTE CORP(INCY)182,101191,627+9,52617,13921,7234.08%+4,583
KARYOPHARM THERAPEUTICS INC(KPTI)897,709940,855+43,1465,0009,1921.73%+4,192
DISC MEDICINE INC(IRON)122,978159,384+36,4067,86311,6572.19%+3,794
CORVUS PHARMACEUTICALS INC(CRVS)891,9331,080,888+188,95513,04916,1483.03%+3,099
STRUCTURE THERAPEUTICS INC255,379276,550+21,17112,30914,8422.79%+2,533
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)0318,407+318,40702,4260.46%+2,426
FRACTYL HEALTH INC(GUTS)5,491,8666,168,749+676,8832,5144,9000.92%+2,386
SYNDAX PHARMACEUTICALS INC(SNDX)1,043,6701,215,698+172,02824,38026,5754.99%+2,195
IMMUNOCORE HLDGS PLC(IMCR)84,352148,045+63,6932,5434,7000.88%+2,157
BRIDGEBIO PHARMA INC(BBIO)432,014455,041+23,02732,08133,8916.37%+1,810
ELEDON PHARMACEUTICALS INC(ELDN)1,639,8161,695,071+55,2555,0516,6791.26%+1,628
HYPERFINE INC(HYPR)1,320,0411,320,04101,4261,7820.33%+356
ATAIBECKLEY INC(ATAI)196,858196,85806971,0370.19%+341
DYNE THERAPEUTICS INC(DYN)282,954244,929-38,0255,1305,4401.02%+310
OUTSET MED INC(OM)118,279118,27904545110.10%+57
METAGENOMI THERAPEUTICS INC(MGX)528,993528,99307096300.12%-79
FAETH THERAPEUTICS INC(FTH)14,71814,71804643680.07%-96
EDWARDS LIFESCIENCES CORP144,607124,778-19,82911,58011,2872.12%-293
PROTARA THERAPEUTICS INC(TARA)580,024520,148-59,8763,0221,9870.37%-1,035
BRISTOL-MYERS SQUIBB CO(BMY)420,727412,961-7,76625,51723,7954.47%-1,722
TYRA BIOSCIENCES INC(TYRA)67,2850-67,2852,5770-2,577
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
83,5540-83,5542,6750-2,675
PHATHOM PHARMACEUTICALS INC(PHAT)247,7670-247,7672,7530-2,753
SUPERNUS PHARMACEUTICALS(SUPN)62,0190-62,0193,2060-3,206
ABIVAX SA(ABVX)47,1930-47,1935,2550-5,255
VERADERMICS INC(MANE)173,58245,856-127,72610,9625,6381.06%-5,324
ULTRAGENYX PHARMACEUTICAL IN(RARE)850,797316,252-534,54517,82410,5601.98%-7,265
UNIQURE NV(QURE)491,1160-491,1168,0300-8,030
KALVISTA PHARMACEUTICALS INC426,5510-426,5518,5860-8,586
ADAPTIVE BIOTECHNOLOGIES COR(ADPT)722,7840-722,78410,0320-10,032
CYTOKINETICS INC(CYTK)215,5010-215,50114,2040-14,204
BOSTON SCIENTIFIC CORP(BSX)299,3180-299,31818,7820-18,782
SOLENO THERAPEUTICS INC577,8080-577,80819,3450-19,345
TERNS PHARMACEUTICALS INC409,0310-409,03121,5640-21,564
ASCENDIS PHARMA A/S(ASND)129,1110-129,11129,5320-29,532
DIANTHUS THERAPEUTICS INC(DNTH)560,30832,941-527,36747,0213,2110.60%-43,810
Page 1 of 1
Catalio Capital Management, LP — 13F Holdings — Q2 2026 | TickerTrail